We've been using the MC38 s.c. tumor model and continue to have issues with tumor ulceration. We have tried injecting in different locations, varying the cell number, varying the resuspension buffer (PBS, RPMI, matrigel), using different cell lots, etc. The cells are myco-free and have been MAP tested. This is not a tumor size issue as the ulcers appear in small tumors (~200 mm3).

Has anyone had success in reducing the ulceration frequency?

More John C Schmitz's questions See All
Similar questions and discussions